A high-normal thyrotropin level is associated with the severity of left ventricular diastolic dysfunction in patients

Shi Chen1, Jiansong Yuan, Shubin Qiao

  • 1Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

Kardiologia Polska
|April 12, 2013
PubMed

Insights

High-normal thyroid-stimulating hormone (TSH) levels are linked to worse left ventricular (LV) diastolic dysfunction in hypertrophic cardiomyopathy (HCM) patients. This suggests TSH may influence heart failure development in HCM.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Left ventricular (LV) diastolic dysfunction is a hallmark of hypertrophic cardiomyopathy (HCM).
  • Elevated thyrotropin (thyroid-stimulating hormone, TSH) levels within the normal range may impact cardiac function.

Purpose of the Study:

  • To investigate the association between increasing TSH levels within the reference range and the severity of LV diastolic dysfunction in HCM patients.

Main Methods:

  • Assessed 152 HCM patients and 119 controls for serum TSH, FT3, and FT4.
  • Quantified LV diastolic function using the E/Ea ratio.
  • Analyzed correlations between TSH levels and diastolic function parameters.

Main Results:

  • HCM patients with high-normal TSH showed significantly higher E/Ea ratios (25.7 ± 5.6 vs. 17.7 ± 4.9, p < 0.001).
  • A significant correlation was found between E/Ea ratio and high-normal TSH levels (β = 0.268, p = 0.021).
  • High-normal TSH predicted severe heart failure in univariate analysis, but not after adjusting for LV diastolic dysfunction.

Conclusions:

  • Hypertrophic cardiomyopathy patients with high-normal TSH levels exhibit increased LV diastolic dysfunction.
  • TSH level variations within the high reference range can exacerbate impaired LV diastolic function.
  • High-normal TSH may contribute to heart failure development in HCM via its association with LV diastolic impairment.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...